The First Time, FDA Cites Sponsor For Failure To Submit Clinical Trial Results To ClinicalTrials.gov
Published:
May 19, 2021
The U.S. Food and Drug Administration (FDA) cites Acceleron Pharma Inc. for failure to submit clinical trial results data to ClinicalTrials.gov within one year after the clinical trial's primary completion date. The Notice of Noncompliance follows on the heels of FDA's August 2020 guidance on its authority to seek civil...
Read More
Read More